JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

JNJ

188.98

-0.04%↓

ABT

123.58

-0.84%↓

TMO

568.01

+2.1%↑

ISRG

534.39

+0.84%↑

DHR

215.62

+0.34%↑

Kodu・Aktsiate loetelu・Myomo Inc

Myomo Inc

Suletud

0.9

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.9

Max

0.91

Põhinäitajad
By Trading Economics
Sissetulek	-1.2M -4.6M
Müük	-180K 9.7M
Kasumimarginaal	-47.989
Töötajad	184
EBITDA	-642K -4.2M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+598.92% upside

Turustatistika
By TradingEconomics
Turukapital	-23M 40M
Eelmine avamishind	0.9
Eelmine sulgemishind	0.9

Myomo Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

2. nov 2025, 22:13 UTC

Tulu

Westpac Raises Dividend Despite 1% Slip in Annual Profit -- Update

2. nov 2025, 21:23 UTC

Tulu

Westpac Raises Dividend Despite 1% Slip in Annual Profit

2. nov 2025, 23:43 UTC

Market Talk

Gold Falls on Reports of China's Finance Ministry Ending Tax Incentive for Gold Sales -- Market Talk

2. nov 2025, 23:34 UTC

Market Talk

Oil Rises as OPEC+ Signals Output-Increase Pause -- Market Talk

2. nov 2025, 21:00 UTC

Tulu

Westpac Has Set Tech Overhaul Goals and Will Share Progress, CEO Says>WBC.AU

2. nov 2025, 21:00 UTC

Tulu

Westpac Is Now Executing on Tech Overhaul, CEO Says>WBC.AU

2. nov 2025, 21:00 UTC

Tulu

Westpac Has Completed Tech Overhaul's Discovery and Planning Phases, CEO Says >WBC.AU

2. nov 2025, 20:55 UTC

Tulu

Westpac FY Australia Mortgage Lending Up 5% on Year>WBC.AU

2. nov 2025, 20:55 UTC

Tulu

Westpac FY Institutional Lending Up 17% on Year>WBC.AU

2. nov 2025, 20:55 UTC

Tulu

Westpac FY Business Lending Up 15% on Year>WBC.AU

2. nov 2025, 20:46 UTC

Tulu

Westpac Expects Completion in 2H of FY 2026>WBC.AU

2. nov 2025, 20:46 UTC

Tulu

Westpac Expects CET1 Capital Ratio to Rise by 20 Basis Points>WBC.AU

2. nov 2025, 20:45 UTC

Tulu

Westpac: Sale Is at Slight Premium to Expected Gross Loan Value at Completion>WBC.AU

2. nov 2025, 20:44 UTC

Tulu

Westpac Selling to Consortium Including KKR, Pimco and Pepper Money>WBC.AU

2. nov 2025, 20:43 UTC

Tulu

Westpac Agrees to Sell A$21.4B Rams Mortgage Portfolio>WBC.AU

2. nov 2025, 20:42 UTC

Tulu

Westpac FY Impairment Provisions A$4.99B Vs. A$5.10B>WBC.AU

2. nov 2025, 20:41 UTC

Tulu

Westpac FY Net Profit Ex-Notable Items A$7.0B, Down 2% on Year>WBC.AU

2. nov 2025, 20:40 UTC

Tulu

Westpac FY Customer Deposits A$723.0B Vs. A$673.6B>WBC.AU

2. nov 2025, 20:39 UTC

Tulu

Westpac FY Total Loans A$851.85B Vs. A$806.77B>WBC.AU

2. nov 2025, 20:37 UTC

Tulu

Westpac FY24 Impairment Charges 5 Bps of Loans Vs. 7 Bps in FY25>WBC.AU

2. nov 2025, 20:37 UTC

Tulu

Westpac FY Operating Expenses A$11.92B Vs. A$10.94B>WBC.AU

2. nov 2025, 20:37 UTC

Tulu

Westpac FY Non-Interest Income A$3.00B Vs. A$2.835B>WBC.AU

2. nov 2025, 20:36 UTC

Tulu

Westpac FY Net Interest Income A$19.38B Vs. A$18.75B>WBC.AU

2. nov 2025, 20:35 UTC

Tulu

Westpac FY CET1 Level 2 Capital Ratio 12.5% Vs. 12.5%>WBC.AU

2. nov 2025, 20:35 UTC

Tulu

Westpac FY Net Interest Margin 1.94% Vs. 1.95%>WBC.AU

2. nov 2025, 20:35 UTC

Tulu

Westpac Raises Dividend to A$0.77 Vs. A$0.76 >WBC.AU

2. nov 2025, 20:34 UTC

Tulu

Westpac FY Rev A$22.38B Vs. A$21.59B >WBC.AU

2. nov 2025, 20:33 UTC

Tulu

Westpac FY Net A$6.92B Vs. Net A$6.99B >WBC.AU

2. nov 2025, 14:27 UTC

Tulu

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

2. nov 2025, 14:25 UTC

Tulu

Warren Buffett Is Leaving Berkshire Hathaway in Great Shape for His Successor After Profit Results -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Myomo Inc Prognoos

Hinnasiht

By TipRanks

598.92% tõus

12 kuu keskmine prognoos

Keskmine 6.5 USD 598.92%

Kõrge 10.5 USD

Madal 4 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Myomo Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

Osta

Hoia

Müü

Põhineb 4 analüütiku instrumendi Myomo Inc aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Myomo Inc

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.